Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 552-562

  Amin, Hesham M ^a   Ergin, Melek ^a   Denning, Mitchell F ^a   Quevedo, Maria E ^a   Alkan, Serhan ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Acute promyelocytic leukaemia; Apoptosis; Caspases; Protein kinase C; Protein kinase C inhibitors

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; CASPASE; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; SAFINGOL;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME TRANSLOCATION 15; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

APOPTOSIS; CARBAZOLES; CASPASES; CELL LINE; DNA FRAGMENTATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GENISTEIN; HUMANS; INDOLES; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTEIN KINASE C; SPHINGOSINE;

EID: 0033776136     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02207.x     Document Type: Article

References (61)

1. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1
2. Genistein, a specific inhibitor of tyrosine-specific protein kinases
3. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17
4. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid
5. Protein kinase C: A worthwhile target for anticancer drugs?
6. All trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
7. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission
8. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3
9. Features of apoptotic cells measured by flow cytometry
10. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein
11. 2C2 adrenergic receptors to G(i) and G(s)
12. Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
13. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia
14. Inhibition of human caspases by peptide-based and macromolecular inhibitors
15. Molecular genetics of human leukemia
16. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry
17. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-β-D-arabinofuranosylcytosine in human leukemia cells
18. Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: Association with enhanced fragmentation of mature DNA
19. Apoptosis: Molecular aspects of cell death and disease
20. Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase C isoenzymes
21. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets
22. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
23. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C
24. Chromosomal translocation t (15;17) in human acute promyelocytic leukaemia fuses RAR α with a novel putative transcription factor, PML
25. Biphasic dose-response curve to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtype?
26. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
27. Strategies for phenotyping apoptotic peripheral human lymphocyte comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods
28. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line
29. p53-Independent apoptosis induced by genistein in lung cancer cells
30. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
31. Protein kinase C and its substrates
32. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia
33. Protein kinase C involvement in apoptosis
34. New strategies for the treatment of acute promyelocytic leukemia
35. Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Go 6976
36. Implications of apoptotic cell death regulation in cancer therapy
37. CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?
38. Caspases: Killer proteases
39. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
40. The expression and possible roles of protein kinase C in haematopoietic cells
41. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
42. Caspases: The proteases of the apoptotic pathway
43. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP
44. Differential expression of protein kinase C isoform genes in three murine erythroleukemia cell variants: Implication for chemical induced differentiation
45. New insights into the regulation of protein kinase C and novel phorbol ester receptors
46. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C
47. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry
48. Non-specific effects of methyl ketone peptide inhibitors of caspases
49. A pilot clinical/pharmacological study of protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
50. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53
51. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation
52. Inhibited apoptosis and drug resistance in acute myeloid leukaemia
53. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
54. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids
55. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome
56. ++ dependent protein kinase
57. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry
58. Atractyloslde-induced release of cathepsin B, a protease with caspase-processing activity
59. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V
60. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
61. Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells